40under40 Website Header_1200x630.png

01 about

40 Under 40 in Cancer is an awards initiative to identify and recognize the contributions being made across the field of cancer by rising stars and emerging leaders under the age of 40 years. Finalists and awardees will be selected by a panel of reviewers from across diverse roles in oncology.


02 eligibility

The nomination period is now open!

Nominations must be submitted by August 13, 2021. Individuals may be nominated in a number of categories, including:​​

  • Clinical and Patient Care Professional

  • Biopharma, Diagnostics, and Devices

  • Research, Science, and Technology

  • Government, Regulatory, and Payer

  • Patient, Advocacy, and Policy

  • COVID-19 Community Advocate


Finalists and awardees will be selected by a panel of reviewers from across diverse roles in oncology. Winners will be chosen based on the content, quality, and substance of the nomination, not on the quantity of nominations received for any one individual. Blank answers or responses will receive a score of zero for that section.

03 awardees

The members of the 2020 40 Under 40 in Cancer class were selected by a panel of judges and include the following:


  • Aaron Lyss, MBA | OneOncology

  • Alan Todd Blank, MD, MS | Midwest Orthopedics at Rush

  • Alexandra Huffman, LCSW, OSW-C | UT Southwestern Medical Center/Simmons Cancer Center

  • Arturo Loaiza-Bonilla, MD, MSEd, FACP | Vidence/Cancer Treatment Centers of America

  • Ayn Wisler | Merck

  • Carmine Attanasio, MBA | Bristol Myers Squibb

  • Chevon Rariy, MD | Cancer Treatment Centers of America

  • Chirag B. Patel, MD, PhD, MSE | Stanford University School of Medicine

  • Danielle Blanch Hartigan, PhD, MPH | Bentley University

  • David Hadley, BSc, MSc, PhD | Inteliquet

  • Donald C. Moore, PharmD, BCPS, BCOP, DPLA | Levine Cancer Institute – Northeast, Atrium Health

  • Dyer Vann | TerSera

  • Elizabeth F. Franklin, PhD, MSW | Cancer Support Community

  • Eric Lim, PhD | Stoke Therapeutics, Inc

  • Gavin Ha, PhD | Fred Hutchinson Cancer Research Center

  • Jacqueline Luma | Ipsen Pharmaceuticals

  • Jason M. Redman, MD | National Institutes of Health

  • Joan Kelly | Janssen

  • Julianne O. Darling, PharmD, BCOP | Indiana University Simon Cancer Center

  • Kate Deen Taucher, PharmD, MHA, BCOP | UCHealth

  • Laura Kleiman, PhD | Reboot Rx

  • Laura Martin, MS, RN, OCN, BMTCN | MedStar Georgetown University Hospital

  • Lauren M. Hamel, PhD | Wayne State University/Karmanos Cancer Institute

  • Megan Dillaman | WVU Medicine

  • Melissa A. Reimers, MD | Washington University School of Medicine in St. Louis

  • Michael Andrew Postow, MD | Memorial Sloan Kettering Cancer Center

  • Misako Nagasaka, MD | Wayne State University

  • Molly Mendenhall, BSN, RN | Oncology Hematology Care

  • Namrata Vijayvergia, MD | Fox Chase Cancer Center

  • Omkar Marathe, MD | The Oncology Institute of Hope and Innovation

  • Nitya Raj, MD | Memorial Sloan Kettering Cancer Institute

  • Robyn M. Scherber, MD, MPH | Incyte & UT Health San Antonio MD Anderson Cancer Center

  • Runcie C.W. Chidebe | Project Pink Blue-Health & Psychological Trust Centre

  • Ryan Haumschild, PharmD, MS, MBA | Emory Healthcare and Winship Cancer Institute

  • Sameer Patel, MD | UC Health Department of Surgery

  • Sara Douglas, MSN, RN, OCN | Masonic Cancer Alliance, The University of Kansas Cancer Center

  • Sarah Elizabeth Pesek, MD, FACS | Trinity Health-St Peter’s Health Partners

  • Shannon McQuillan Norris | Shannon’s Comfy Chemo Care Bag Project Inc.

  • Shelly Rosenfeld | Cancer Legal Resource Center

  • Srulik Dvorsky | Tailormed

  • Stephanie R. Harris, MHA, RN, OPN-CG | Oklahoma City Indian Clinic

  • Sumanta Kumar Pal, MD | City of Hope

  • Tara FitzPatrick-Forbes | Bayer

  • Thomas U. Marron, MD, PhD | Tisch Cancer Institute, Mount Sinai Hospital

  • Triparna Sen, PhD | Memorial Sloan Kettering Cancer Center


Congratulations to all of the nominees and awardees!


04 contact